December 2025

In the early 2000s, I was a junior project manager on a major pharmaceutical initiative. The task was twofold: develop the active ingredient for a new epilepsy drug called Gabapentin and construct a dedicated manufacturing facility. For any project manager, this was the ultimate “Triple Constraint” challenge: managing scope, schedule, and budget under immense pressure.Our…

When most people think of India’s pharma exports, they picture pills made for the U.S. or Europe. But the real story of growth today lies in emerging markets like Africa, Latin America, and Southeast Asia. These regions are transforming from peripheral destinations into strategic battlegrounds for India’s pharmaceutical giants. With soaring demand, rising healthcare access,…

If you work in generic pharma portfolio management, chances are you spend epic amounts of time locked up with a spreadsheet the size of a small continent. Molecules and dosage forms, therapeutic areas, sales channels, market shares, LoE dates, patent minefields to traverse, bioequivalence complexities, API costs and dossier suppliers, capacity constraints and on, and…